Find it Early

Premium

Amos Douvdevani, director of the laboratory of nephrology at Soroka University Medical Center and Ben-Gurion University in Be'er Sheva, Israel, and his colleagues have developed a new assay to detect significant levels of cell-free DNA in patients with cancer that is simpler to perform than currently available assays. The researchers used their test to evaluate patients with primary colorectal cancer and demonstrated that the new method was capable of reporting CFD levels that were prognostic of disease and outcome.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.